orphan drug造句

Is it time to revisit orphan drug policies?

Sabril was designated as an orphan drug by the FDA for use in treating infantile spasms.

ABSTRACT: OBJECTIVE: to introduce high-value drug insurance access mechanism in Australia, and to provide suggestion for improving orphan drug medical insurance access in China.

The European orphan diseases market grapples with numerous challenges. Of these, the most serious are the lack of awareness, poor diagnosis and limited accessibility of orphan drugs.

EU healthcare ministers should encourage frequent discussions with patients, patient support groups and industry representatives to ensure a transparent and rapid approval process for orphan drugs.